A new trade deal between the United States and United Kingdom could result in more than 200,000 otherwise avoidable deaths in England by diverting billions of pounds away from vital health services, according to a new analysis.
Trade Deal Details
In December, the UK agreed with Washington DC to increase the UK’s spending on new medicines from 0.3% of GDP to at least 0.6% over the next decade as part of a broader deal aimed at avoiding punitive tariffs threatened by President Donald Trump.
The analysis published in The British Medical Journal (BMJ) said the deal is expected to cost the UK’s publicly funded National Health Service (NHS) an additional £45 billion ($60 billion) by the end of 2036 to pay for the new medicines.
Unless the UK government provides extra money, redirecting funds away from services in the NHS could lead to 229,000 extra deaths and exacerbate health inequalities in the country, according to the analysis.
Original reporting: KTVZ (Central Oregon) — read the source article.
